Bobby Reddy, Jr., Co-founder and CEO of Prenosis, appeared live on NewsNation Now for an in-depth, one-on-one interview about the transformative role of artificial intelligence in sepsis care. Airing just days after the FDA authorized the Sepsis ImmunoScore™, the discussion highlighted how this groundbreaking tool is revolutionizing acute care. NewsNation Now is a nationally broadcast news platform, reaching millions of viewers across the United States.
Science
Science, technology and the emergence of AI have converged to make precision medicine for acute care a reality. This is how we deliver healthcare tailored to biology.
Research & Development
Evidence
Clinical Trials
The Sepsis ImmunoScore® Predicts Sepsis, Mortality, and Deterioration Better than Clinical Scores and Widely Available Biomarkers
Read More →
Products
Prenosis is developing a pipeline of integrated diagnostics and therapeutics grounded in each patient's unique biological profile, using deep data science and AI to give clinicians tools that reflect the true complexity of critical disease.
Immunix®
Sepsis ImmunoScore®
BioAegis Therapeutics Announces Collaboration with Prenosis to Advance AI-Driven Precision Medicine in Inflammatory Disease
Read More →
Resources
Blogs, articles, videos, and podcasts exploring how precision medicine and AI are changing the way clinicians detect and treat critical conditions.
Resource Library
Events
Treating the Patient, Not the Disease
Read More →
Newsroom
Read the latest Prenosis peer-reviewed articles and items from scholarly journals.
Newsroom
Sepsis ImmunoScore Outperforms Conventional Sepsis Tools
Read More →
About
As a biology-based technology company, we combine data science with AI to transform how critical conditions are diagnosed and treated.
Mission, Vision & Values
Careers
Leadership
Awards
LifeBridge Health deploys Prenosis’ FDA-authorized AI tool to speed sepsis detection
Read More →